Dyadic International Inc.

DYAI

Healthcare Biotechnology

Dyadic International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 million, down 11.6% from fiscal 2024.

Revenue
−61.4%
EPS
n/m
Free cash flow
n/m
Total debt
+0.80%

Quarter to September 2026, against a year earlier

0.33 0.02 −5.71%
Market cap
$14.0M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
2/9
ROIC
0.00%
Net debt / EBITDA
0.5×
Payout ratio
—

What it owns vs. what it owes End of fiscal 2025, 31 December 2025

It holds $3.5M more in cash and short-term investments than it owes in debt. Shareholders’ equity is 12% of the balance sheet. What is a balance sheet?

31 December 2025 · total $9.9M

Owns

$49.0KLong-term assets
$1.3MOther short-term assets
$8.6MCash & short-term investments

Funded by

$1.2MShareholders’ equity
$3.7MOther liabilities
$5.0MDebt

Debt is 50.5% of the total; shareholders’ equity 12.4%.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Cash and Short Term Investments
8.55 9.26 7.26 12.64 20.26 29.09 34.22 41.20 47.69 56.30
Receivables
1.13 0.26 0.48 0.39 0.37 0.41 1.14 1.12 0.76 1.08
Total current assets
9.90 9.83 8.07 13.42 21.01 29.78 35.64 42.75 49.62 57.63
Long-Term Investments
— — — 0.28 0.28 0.28 1.51 — 0.92 1.07
Long-term receivables
— — — — — — 0.25 0.50 — —
Long-term assets (Other)
0.01 0.01 0.01 0.01 0.01 0.01 0.05 0.05 0.05 0.01
Total non-current assets
0.05 0.10 0.15 0.29 0.29 0.29 1.81 0.55 0.98 —
Total Assets
9.95 9.93 8.22 13.71 21.30 30.07 37.45 43.30 50.74 —
Accounts Payable
0.85 0.48 0.66 1.28 1.55 1.01 0.94 0.31 0.52 0.28
Accrued Expenses
1.07 1.08 1.06 0.96 0.71 0.49 0.57 0.40 0.15 —
Current Revenue (Deferred)
1.73 0.83 0.49 0.22 0.30 0.12 0.08 0.14 — —
Total current liabilities
3.69 2.45 2.25 2.45 2.56 1.63 1.59 0.85 0.77 1.01
Long Term Debt (Total)
5.03 4.98 — — — — — — — —
Non-current Revenue (Deferred)
— — — 0.18 0.35 — — — — —
Total non-current liabilities
5.03 5.01 0.09 0.18 0.35 — — — — —
Total liabilities
8.71 7.46 2.34 2.63 2.91 1.63 1.59 0.85 0.77 1.01
Additional Paid In Capital
113.57 107.44 105.04 103.46 101.03 98.01 96.11 94.39 93.91 —
Common Stock (Net)
0.05 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Retained Earnings
(93.45) (86.09) (80.28) (73.48) (63.75) (50.68) (41.35) (33.04) (27.35) (25.20)
Treasury Stock
18.93 18.93 18.93 18.93 18.93 18.93 18.93 18.93 16.63 —
Common Equity (Total)
1.23 2.47 5.88 11.09 18.39 28.45 35.86 42.45 49.98 57.69
Shareholders Equity (Total)
1.23 2.47 5.88 11.09 18.39 28.45 35.86 42.45 49.98 57.69
Shareholders Equity and Liabilities (Total)
9.95 9.93 8.22 13.71 21.30 30.07 37.45 43.30 50.74 —
Shares (Common)
36.19 29.84 28.81 28.56 28.23 27.49 27.36 26.71 28.33 —
Shareholders Equity (Tangible)
1.23 2.47 5.88 11.09 18.39 28.45 35.86 42.45 49.98 —
Net Debt
(3.53) (4.29) (7.26) (12.64) (20.26) (29.09) (34.22) (41.20) (47.69) (56.30)
Total Debt
5.03 4.98 — — — — — — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 13 Nov 2026